UPDATE: JPMorgan Starts Momenta Pharmaceuticals (MNTA) at Overweight
Tweet Send to a Friend
(Updated - November 13, 2015 11:32 AM EST)
JPMorgan initiated coverage on Momenta Pharmaceuticals (NASDAQ: MNTA) with an Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan initiated coverage on Momenta Pharmaceuticals (NASDAQ: MNTA) with an Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
